SOX9 and oligodendroglioma: For GPR17, its expression was more confined to OLIG1+ cells in the oligodendroglioma (Figure 2A,B), whereas a similar expression was found in the SOX9+ and OLIG1+ subpopulations in the explored astrocytoma (Figure S4A,B).